دورية أكاديمية
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study
العنوان: | Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study |
---|---|
المؤلفون: | Poon, RTP, Decaens, T, Raoul, JL, Llovet, JM |
بيانات النشر: | //www.jco.org/ United States |
سنة النشر: | 2013 |
المجموعة: | University of Hong Kong: HKU Scholars Hub |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 0732-183X |
العلاقة: | Journal of Clinical Oncology; Journal of Clinical Oncology, 2013, v. 31 n. 28, p. 3509-3516; 3516; 227170; WOS:000330539000009; 28; 3509; http://hdl.handle.net/10722/193243Test; 31 |
DOI: | 10.1200/JCO.2012.47.3009 |
الإتاحة: | https://doi.org/10.1200/JCO.2012.47.3009Test http://hdl.handle.net/10722/193243Test |
رقم الانضمام: | edsbas.A4FA9381 |
قاعدة البيانات: | BASE |
تدمد: | 0732183X |
---|---|
DOI: | 10.1200/JCO.2012.47.3009 |